Regulatory Roundup: UDI Guidance, Class I Recall
This article was originally published in The Gray Sheet
Executive Summary
FDA issued a guidance document on its unique device identification system primarily targeting small business, and it classified hyaluronic acid-based intranasal splint recall as class I.